AntiviralsLipohypertrophy and acquired resistance: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2043卷 / 1期

关键词：

D O I：

10.1007/s40278-025-75331-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：50 / 50

相关论文

共 50 条

[31] Multiple drugsLack of efficacy and acquired drug resistance: 5 case reports
Reactions Weekly, 2020, 1806 (1) : 194 - 194
[32] VoriconazoleDevelopment of resistance: 2 case reports
Reactions Weekly, 2019, 1781 (1) : 343 - 343
[33] OsimertinibDevelopment of resistance: 2 case reports
Reactions Weekly, 2020, 1800 (1) : 239 - 239
[34] OsimertinibDrug resistance: 2 case reports
Reactions Weekly, 2021, 1867 (1) : 338 - 338
[35] GefitinibAcquired resistance: 2 case reports
Reactions Weekly, 2021, 1869 (1) : 163 - 163
[36] LinezolidDrug resistance: 2 case reports
Reactions Weekly, 2019, 1777 (1) : 153 - 153
[37] RuxolitinibDevelopment of resistance: 2 case reports
Reactions Weekly, 2015, 1566 (1) : 204 - 204
[38] VenetoclaxDrug resistance: 2 case reports
Reactions Weekly, 2022, 1900 (1) : 321 - 321
[39] AntiviralsDrug resistance: 2 case reports
Reactions Weekly, 2023, 1947 (1) : 77 - 77
[40] GefitinibDrug resistance: 2 case reports
Reactions Weekly, 2017, 1657 (1) : 207 - 207

← 1 2 3 4 5 →